Granulocyte colony-stimulating factor reverses septic shock-induced polymorphonuclear leukocyte dysfunction

H H Simms1, R D'Amico

  • 1Department of Surgery, Brown University School of Medicine-Rhode Island Hospital, Providence 02903.

Surgery
|January 1, 1994
PubMed
Abstract

Insights

Septic shock significantly reduces CD64 (Fc gamma RI) expression on polymorphonuclear leukocytes (PMNs). Granulocyte colony-stimulating factor can restore CD64 function, improving PMN oxidative metabolism and degranulation in patients with septic shock.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Polymorphonuclear leukocyte (PMN) function relies on Fc gamma receptor expression.
  • Fibronectin and laminin modulate CD32 (Fc gamma RII) and CD16 (Fc gamma RIII) but their effect on CD64 (Fc gamma RI) was unclear.

Purpose of the Study:

  • To define the role of CD64 (Fc gamma RI) in modulating PMN oxidative metabolism and degranulation.
  • To investigate the effects of fibronectin and laminin on CD64 expression and function in PMNs.

Main Methods:

  • PMNs from healthy volunteers and patients (controls and septic shock) were analyzed.
  • CD64 expression was measured after adherence to fibronectin or laminin.
  • Oxidative metabolism and degranulation were assessed via superoxide anion, hypochlorous acid, and N-acetyl-beta-glucosaminidase production.
  • Cytokines were tested for their ability to restore CD64 activity in septic shock patients.

Main Results:

  • Fibronectin and laminin increased CD64 expression and activity in PMNs from healthy volunteers and control patients.
  • Septic shock patients showed depressed CD64 expression and activity.
  • Granulocyte colony-stimulating factor restored both CD64 expression and biological activity in septic shock PMNs.

Conclusions:

  • Septic shock impairs CD64 expression on PMNs.
  • Granulocyte colony-stimulating factor can restore CD64 number and function, enhancing PMN oxidative metabolism and degranulation in the context of fibronectin or laminin.
  • This suggests a potential therapeutic target for sepsis-related immune dysfunction.